FPH.NZ - Fisher & Paykel Healthcare Corporation Limited

NZSE - NZSE Delayed price. Currency in NZD
+0.15 (+1.17%)
At close: 5:00PM NZDT
Stock chart is not supported by your current browser
Previous close12.80
Bid12.95 x 154300
Ask13.00 x 392000
Day's range12.78 - 13.17
52-week range9.41 - 14.49
Avg. volume684,159
Market cap7.39B
PE ratio (TTM)43.17
EPS (TTM)0.30
Earnings date28 May 2018
Forward dividend & yield0.28 (2.15%)
Ex-dividend dateN/A
1y target est12.37
  • AAP4 months ago

    Fisher & Paykel wins patent court case

    Fisher & Paykel Healthcare has won a patent case against rival medical products manufacturer ResMed, after a court in the United Kingdom ruled the patent claim invalid. In 2016, New Zealand-based Fisher & Paykel sought a declaration from the High Court that three of ResMed's European patents were invalid in the UK and should be revoked. ResMed revoked two of its patents in the UK just before the trial was due to start, but left one for consideration by the High Court's patents division.

  • NZ Newswirelast year

    Former F&P; staffer pleads guilty

    A former Fisher & Paykel employee has admitted to corruption-related charges after receiving $213,000 in payments from Middle Eastern companies.

  • We're sorry this is all we were able to find about this topic.